The Psychedelic Pharmaceutical Market Projected to Hit $17B in Next Decade
The global market for these compounds reached $4.75 billion in 2025. Analysts project growth to $16.93 billion by 2034.
Read More
The global market for these compounds reached $4.75 billion in 2025. Analysts project growth to $16.93 billion by 2034.
Read More
This proposal introduces mandatory registration for clinics and establishes strict standards for patient monitoring.
Read More
Spravato has reached blockbuster status and treated more than 200,000 patients. Industry demand trends reveal what that growth means for
Read More
LSD, psilocybin, DMT, mescaline, and ayahuasca all produce the same neural fingerprint when their consciousness-altering effects take hold.
Read More
Here's why ketamine clinics are the infrastructure that defines the next era of psychedelic medicine — and what operators should
Read More
We just negotiated GPO-level medical supply pricing exclusively for Healing Health Alliance members. The proof: one HHA member ketamine practice
Read More
We ranked Hartford's 5 best ketamine clinics for 2026: insurance-billed Spravato programs plus physician-led IV infusions.
Read More
MDMA assisted therapy for PTSD appears to be back in front of the FDA. Psychedelic Alpha reported on August 9
Read More
These three books about psychedelics can serve as a guiding light following an experience.
Read More
$300 for a microdose? A price list for Oregon's first psilocybin service center shocked mushroom lovers. What can we learn
Read More